Vaxxinova presents corporate movie
Nijmegen, NL – January 17, 2022 – Vaxxinova proudly presents its brand new corporate video. It gives an impression on our commitment to animal health, animal welfare and one health. Vaxxinova, we care.
Vaxxinova Buys Newport Laboratories from Boehringer Ingelheim
Worthington, MN – Sept. 30, 2021 – Vaxxinova announced today that it has purchased Newport Laboratories, a company that manufactures custom-made vaccines for swine and cattle, from Boehringer Ingelheim. About 100 people work at Newport Laboratories in Worthington, Minnesota. They help veterinarians and livestock producers address animal health issues through diagnostic testing and production of […]
Webinar Autogenous Vaccines on May 27th
May 6, 2021 – Cuxhaven, Germany On May 27th, 2021 at 4 PM CET Dr. Heike Bigmore, KAM with Vaxxinova Autogenous Vaccines GmbH, will talk about the use of autogenous vaccines as a tool in disease control and mitigation of antimicrobial resistance (AMR) in animal production. The webinar, hosted by EW Nutrition, is titled Autogenous […]
Vaxxinova US Announces USDA Approval of Vaxxon® SRP® Pasteurella
March 15, 2021 – Wilmar, MN, USA Vaxxinova US is announcing USDA approval of their new Vaxxon® SRP® Pasteurella vaccine. Categorized by USDA as a Pasteurella Multocida Bacterial Extract, it is an effective, innovative and safe vaccine against fowl cholera in chickens. Vaxxon SRP Pasteurella provides the industry a new category for long-term protection of […]
Vaxxinova US gains market rights to SRP cattle vaccine from Zoetis
Dec 16, 2020 – Wilmar, MN, USA Vaxxinova US has acquired marketing rights from Zoetis for a vaccine against Salmonella in cattle. Until now, the SRP Salmonella vaccine – the first USDA-licensed vaccine to use SRP technology – was manufactured by Vaxxinova US but marketed by Zoetis. With the latest license acquisition, Vaxxinova US now […]
“Boerderij” article on autogenous vaccines
Dutch farmers Magazine “Boerderij” published an article on autogenous vaccines in its June 16, 2020 edition. The article mentions how autogenous vaccines can contribute to reduced antibiotic use in swine and Vaxxinova’s contribution to this. Read the full article here.
Vaxxinova announces Director R&D and Director RA
Nijmegen, The Netherlands, Wednesday June 3, 2020. Vaxxinova® Nederland BV is pleased to announce two new directors to its team as per June 1, 2020. Both positions are based in Nijmegen. Mrs. Mirjam van der Sluijs will take up the role of Director R&D Nijmegen. As Director R&D Nijmegen Mirjam will lead the R&D and […]
Appointment Managing Director for Vaxxinova Norway and Chile
Nijmegen, The Netherlands, Tuesday June 2, 2020. Vaxxinova® International announces that starting June 1, 2020, Dr. Matias del Campo will be the Managing Director for Vaxxinova Norway and Vaxxinova Chile. Matias will be responsible for the global cold-water aquaculture business. Matias is an Aquaculture Engineer from the University Andres Bello in Chile and holds a […]
Vaxxon® SRP® SE licensed in USA
Nijmegen, The Netherlands, Wednesday January 22, 2020. Vaxxinova is pleased to announce that last week the USDA granted Epitopix the license for Vaxxon® SRP® SE, a poultry vaccine which has been shown to have an effect against colonization of Salmonella Enteritidis in the reproductive tract. Vaxxon® SRP® SE uses innovative siderophore receptor and porin (SRP) […]
Vaxxinova invites you to IPPE 2020
Nijmegen, The Netherlands, Friday January 17, 2020. In January 2020, Vaxxinova will be present at the IPPE 2020 trade show in Atlanta. Our team is ready to meet you at booth C10361. The show is open to visitors on Tue Jan 28 (10 AM – 5 PM), Wed Jan 29 (9AM – 5PM), Thu Jan […]